Document is current

Documents that mention this clinical trial

POS0259 A RANDOMIZED CLINICAL TRIAL OF 2-WEEK METHOTREXATE DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS VACCINATED WITH INACTIVATED SARS-COV-2 VACCINE
https://doi.org/10.1136/annrheumdis-2022-eular.4890

Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial
https://doi.org/10.1136/annrheumdis-2021-221916

Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases
https://doi.org/10.1136/annrheumdis-2021-222096

09 COVID-19 vaccine in lupus patients
https://doi.org/10.1136/lupus-2022-la.9

Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis
https://doi.org/10.1136/annrheumdis-2021-221735